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Dr Frank Pigula (Boston, Mass). First, I’d like the audience to
recognize how difficult it is to perform a study like this, hundreds
of patients over several years with intensive interpretation of a lot
of data, and there are a tremendous amount of data in this article,
and you should be congratulated with your team.
After reading your article, I was left with 2 contradictory
impressions. The first was one of relief and some pleasant surprise,
really, that the SV group, including the HLHS group, performs
comparably to the BV group. Both were generally within 1 SD
of the normative mean for most domains tested, and that’s the
good news.
The second impression was some mild disappointment in that
despite the satisfactory performance of many of these domains,
up to 10% of the patients still scored 2 SDs or below the normative
mean. There were persistent deficits in the visual-motor
integration, as you mentioned, and the processing speed despite
the best efforts.
Now, although we as a community have focused strenuously on
preventing ND injuries in these patients, we’re obviously not
always successful. You have gone through many of the1282 The Journal of Thoracic and Cardiovascular Survariables, operative management variables here, that don’t seem
to necessarily protect one group versus another.
If the money is not in managing those perioperative variables,
circulatory arrest time, the number of operations, and so forth,
should we be looking elsewhere? For instance, is there a role for
remediation? Have any of these patients been introduced to early
intervention or other developmental programs to your knowledge?
Dr Gaynor. At the time of this study, there was no formal
neurocardiac follow-up program. I agree. Now, we in Boston
and many other institutions, have introduced formal neurocardiac
programs. We know this has worked to some extent in the preterm
infants and very low birth rate infants. Neonatal follow-up
programs (early intervention) have resulted in some improvement
of outcomes. It’s a good hypothesis that we should definitely be
following these children and trying to intervene. We need to check
the results and see if that actually does improve outcome.
One of the things that’s becoming of increasing importance is
the nature of the state of the brain before these children even
come to the operating room, at the time that they’re born. Studies
by Catherine Limperopoulos, Pat McQuillen, Steven Miller, and
Dan Licht have shown that brain development, particularly in
the third trimester, is greatly delayed in children with all forms
of CHD. Brain volumes brain maturation, and complexity are
lower, and this probably results in a brain that’s similar to a
preemie brain when they’re born. That probably means in part
that there is an immature population of oligodendrocytes who
are going to be more vulnerable to hypoxic-ischemic injury.
White matter injury is what leads to issues such as executive
function disorders and visual-motor integration disorders; the
white matter traps are disturbed.
There is an article that just came out in Circulation from
New Zealand and Australia showing that the maturation score at
the time of birth was the strongest predictor of ND outcomes at
2 years of age, so brain immaturity. We need to begin looking
outside the operating room and at ways to protect these vulnerable
brains both preoperatively and postoperatively.
Dr Pigula. You’ve alluded in the article to previous studies,
some of which have found differences with the SV in terms of their
outcomes and others that really haven’t. But looking over the data
and your presentation, the management differences between the 2
groups were really striking. The SV cases had multiple operations
and multiple exposures to circulatory arrest. The BV repair is
generally 1 operation, and less than half of those were exposed
to circulatory arrest and for shorter times.
I was struck by the similarity of the ND data. In your thinking
about this in preparation of the article, how do you account for
the discrepant findings from what you found here and what seems
to be the complete disregard for operative management in terms of
outcomes and how you would reconcile those?
Dr Gaynor. If you look at the most recent data on early ND
outcomes for this population from the Single Ventricle Recon-
struction trial, which was recently published a year ago and had
more than 300 kids with HLHS who came back and had an ND
evaluation at 14 months of age, the results are similar. No operative
management strategies were found. The blood gas management,
use of cerebral reperfusion, use of DHCA, and bypass time were
not found to be important. Maternal education, socioeconomic fac-
tors, the presence of genetic anomalies, the longer length of stay,gery c April 2014
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Dand mechanical ventilation were important factors. What this
means is some of those are just a marker of general sickness.
The longer you’re in an intensive care unit and on ventilation,
you may have more risk for injury, maybe even low cardiac output.
I think that confirms the findings here. But it’s not the operative
variables that are important; we need to be broadening our view-
point to look at how to protect these brains.
Dr Pigula. When you’re counseling these families and the
parents, and this question does come up, as it invariably does
many times, I’m just wondering how you counsel them?
DrGaynor. I always tell them that there is a risk of brain injury;
I specifically mention stroke and seizure, which are fairly low; and
I say that a lot of these kids will have some sort of developmental
problems or learning disability, and that we have a neurocardiac
follow-up clinic and that we need to follow them very carefully.
That’s usually my base; if they have additional questions, I go
into more detail.
Dr Christian Pizarro (Wilmington, Del). Bill, that was a beau-
tiful presentation and a fascinating data set. Did you have the
opportunity to look at the patients who follow a pathway of a
bidirectional Glenn followed by extracardiac Fontan versus the
patients who had a hemi-Fontan followed by a lateral tunnel, using
additional periods of circulatory arrest later in life. There is still
enough controversy that surgeons prefer one pathway over the
other, and with the idea that if you minimize circulatory arrest
occurrences over time, your developmental outcome is going to
be better. I wonder if you had an opportunity to look at that.
Dr Gaynor. We did not break it down by that. We do have
children who had both pathways. In general, the Glenn was done
without circulatory arrest and the hemi-Fontan was used only
with a short period of circulatory arrest. But I have not broken
down the data to try to look at that with any SVs.
Dr Pizarro. Last year we presented ND outcome data from our
institution at this meeting, and to our surprise we found that
patients tended to score better on the fine motor skills rather
than on the gross motor component, and we didn’t know if it
was because of the order sequence of the domains tested. Is that
something you found and is that concurrent with your previous
data?
Dr Gaynor. Gross motor skills were usually tested by just the
examiners: the normal, abnormal, suspect. We tested fine motor
with the group pegboard. There clearly are fine motor deficits,
but we haven’t correlated those to look at gross and fine.
Dr Pizarro. I see that you included patients with known genetic
syndromes. Obviously we would expect those patients would have
a worse neurodevelopment. During the analysis, did you control
for that in your multivariate model, and if so, did circulatory arrestThe Journal of Thoracic and Carcontinue to be absent from the model, and how do you think this
might have influenced your observation?
Dr Gaynor. When we looked at the predictors within the
Fontan subgroup, genetic anomaly and circulatory arrest were
included as candidate predictors. So the fact that genetic anomalies
came out in 1 or 2 of the analyses suggests that they are an
independent predictor, and circulatory arrest did not come out in
any of the multivariate models. So they were both included in
the model.
Dr Carl Backer (Chicago, Ill). I have a quick comment and
question. John Costello gave a talk on Saturday about the
influence of gestational age on mortality. I see that it is one
of the factors that you found important. That may be an alter-
able factor in some cases. So I think all of us need to go out
and spread the word that 39 or 40 weeks is when these babies
should be delivered, not earlier. Do you have a comment on
that?
Dr Gaynor. At this meeting 2 years ago, we presented our data
showing that younger gestational age, even in the subgroup of 36 to
38 weeks, each week of younger gestational age is associated with
a decrement in performance. So even within what’s thought to be
near term, earlier gestational age is associated with a worse
outcome. So I would agree completely. The American College
of Obstetricians and Gynecologists now recommends that there
be no elective delivery, induction or C-section, before 39 weeks,
even for normal children. So I think our data match the Boston
data, John Costello’s data, where prematurity, even mild degrees,
37 or 38 weeks, is associated with increased mortality and longer
intensive care unit stays, and we can show worse ND outcomes at
4 years of age.
Dr V.Mohan Reddy (Stanford, Calif). What do you dowith the
patients who are already prematurely born? Is it better to wait
until they mature or leave them on ventilation and unstable
hemodynamics? It’s a tough call.
Dr Gaynor.We individualize. In general, we don’t wait a long
time. We usually go ahead. I mean it’s a factor we have to deal
with; we usually go head and fix the children. Recently, in some
children who are premature with a variety of lesions, particularly
if they have severe lung disease or something else, we use a
hybrid procedure to try to stay off bypass and improve their
hemodynamics. That’s been successful in some of the children.
But I agree, I don’t think waiting for growth is going to help
because that may be the worst time; there is runoff from a
ductus, they may be hypoxic, there is vulnerable white matter,
and that’s probably one of the worst things you can do for brain
development.
Dr Reddy. I agree.diovascular Surgery c Volume 147, Number 4 1283
